• / Free eNewsletters & Magazine
  • / My Account
Home>Quotes>Mood Media Corp

Mood Media Corp

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

    Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

  2. Volvo’s First Electric Hybrid in Commercial Service in Hamburg, Germany

    Volvo’s First Electric Hybrid in Commercial Service in Hamburg, Germany

  3. British GDP Likely to Get Upwards Revision

    British GDP Likely to Get Upwards Revision

  4. STAG Industrial Announces $600 Million Refinancing Of Unsecured Revolving Credit Facility And Term Loans

    STAG Industrial Announces $600 Million Refinancing Of Unsecured Revolving Credit Facility And Term Loans

  5. Nuveen California AMT-Free Municipal Income Fund Completes Preferred Share Issuance

    Nuveen California AMT-Free Municipal Income Fund Completes Preferred Share Issuance

  6. Vermilion Energy Inc. Announces 2015 Guidance

    Vermilion Energy Inc. Announces 2015 Guidance

  7. Eurozone Business Surveys Set to Edge Up in December

    Eurozone Business Surveys Set to Edge Up in December

  8. EndoGastric Solutions Advances EsophyX® Platform with the Launch of EsophyX®2 HD Device

    EndoGastric Solutions Advances EsophyX® Platform with the Launch of EsophyX®2 HD Device

  9. Takeda Presents Phase 2 Data on Maintenance with Single-Agent Investigational Ixazomib in Patients with Newly Diagnosed Multiple Myeloma

    Takeda Presents Phase 2 Data on Maintenance with Single-Agent Investigational Ixazomib in Patients with Newly Diagnosed Multiple Myeloma

  10. Takeda Announces Formalization of Takeda Oncology to Enhance Discovery, Development and Global Commercialization of Breakthrough Cancer Medicines

    Takeda Announces Formalization of Takeda Oncology to Enhance Discovery, Development and Global Commercialization of Breakthrough Cancer Medicines

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.